{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:53:40Z","timestamp":1792684420826,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W014432\/1"],"award-info":[{"award-number":["MR\/W014432\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The number of medications prescribed during pregnancy has increased over the past few decades. Few studies have described the prevalence of multiple medication use among pregnant women. This study aims to describe the overall prevalence over the last two decades among all pregnant women and those with multimorbidity and to identify risk factors for polypharmacy in pregnancy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study was conducted between 2000 and 2019 using the Clinical Practice Research Datalink (CPRD) pregnancy register.<\/jats:p>\n                <jats:p>Prescription records for 577 medication categories were obtained. Prevalence estimates for polypharmacy (ranging from 2+ to 11+ medications) were presented along with the medications commonly prescribed individually and in pairs during the first trimester and the entire pregnancy period.<\/jats:p>\n                <jats:p>Logistic regression models were performed to identify risk factors for polypharmacy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the first trimester (812,354 pregnancies), the prevalence of polypharmacy ranged from 24.6% (2+ medications) to 0.1% (11+ medications). During the entire pregnancy period (774,247 pregnancies), the prevalence ranged from 58.7 to 1.4%.<\/jats:p>\n                <jats:p>Broad-spectrum penicillin (6.6%), compound analgesics (4.5%) and treatment of candidiasis (4.3%) were commonly prescribed. Pairs of medication prescribed to manage different long-term conditions commonly included selective beta 2 agonists or selective serotonin re-uptake inhibitors (SSRIs).<\/jats:p>\n                <jats:p>Risk factors for being prescribed 2+ medications during the first trimester of pregnancy include being overweight or obese [aOR: 1.16 (1.14\u20131.18) and 1.55 (1.53\u20131.57)], belonging to an ethnic minority group [aOR: 2.40 (2.33\u20132.47), 1.71 (1.65\u20131.76), 1.41 (1.35\u20131.47) and 1.39 (1.30\u20131.49) among women from South Asian, Black, other and mixed ethnicities compared to white women] and smoking or previously smoking [aOR: 1.19 (1.18\u20131.20) and 1.05 (1.03\u20131.06)]. Higher and lower age, higher gravidity, increasing number of comorbidities and increasing level of deprivation were also associated with increased odds of polypharmacy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The prevalence of polypharmacy during pregnancy has increased over the past two decades and is particularly high in younger and older women; women with high BMI, smokers and ex-smokers; and women with multimorbidity, higher gravidity and higher levels of deprivation. Well-conducted pharmaco-epidemiological research is needed to understand the effects of multiple medication use on the developing foetus.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-022-02722-5","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T13:03:33Z","timestamp":1673874213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Polypharmacy during pregnancy and\u00a0associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8875-7363","authenticated-orcid":false,"given":"Anuradhaa","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3307-878X","authenticated-orcid":false,"given":"Amaya","family":"Azcoaga-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0494-321X","authenticated-orcid":false,"given":"Astha","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0674-605X","authenticated-orcid":false,"given":"Katherine","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2332-5452","authenticated-orcid":false,"given":"Siang Ing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6991","authenticated-orcid":false,"given":"Neil","family":"Cockburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9184-8258","authenticated-orcid":false,"given":"Adeniyi Francis","family":"Fagbamigbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5018-0108","authenticated-orcid":false,"given":"Christine","family":"Damase-Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7615-8523","authenticated-orcid":false,"given":"Christopher","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9466-833X","authenticated-orcid":false,"given":"Colin","family":"McCowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-0652","authenticated-orcid":false,"given":"Dermot","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0427-1783","authenticated-orcid":false,"given":"Gillian","family":"Santorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4834-6719","authenticated-orcid":false,"given":"Holly","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1122-6502","authenticated-orcid":false,"given":"Jonathan I.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3538-8896","authenticated-orcid":false,"given":"Kathryn M.","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3689-0490","authenticated-orcid":false,"given":"Kelly-Ann","family":"Eastwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8109-1930","authenticated-orcid":false,"given":"Louise","family":"Locock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6841-8601","authenticated-orcid":false,"given":"Mairead","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-3637","authenticated-orcid":false,"given":"Maria","family":"Loane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-5072","authenticated-orcid":false,"given":"Ngawai","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9908-0773","authenticated-orcid":false,"given":"Rachel","family":"Plachcinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4254-460X","authenticated-orcid":false,"given":"Shakila","family":"Thangaratinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7417-2858","authenticated-orcid":false,"given":"Sinead","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5181-6120","authenticated-orcid":false,"given":"Utkarsh","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6989-2180","authenticated-orcid":false,"given":"Zoe","family":"Vowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9950-6751","authenticated-orcid":false,"given":"Peter","family":"Brocklehurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6639-5904","authenticated-orcid":false,"given":"Helen","family":"Dolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9311-1196","authenticated-orcid":false,"given":"Catherine","family":"Nelson-Piercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6816-1279","authenticated-orcid":false,"given":"Krishnarajah","family":"Nirantharakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the MuM-PreDiCT Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"2722_CR1","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/S0140-6736(21)02550-2","volume":"398","author":"SI Lee","year":"2021","unstructured":"Lee SI, et al. Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a cross-sectional study. Lancet. 2021;398:S7.","journal-title":"Lancet"},{"key":"2722_CR2","unstructured":"Birth characteristics in England and Wales - Office for National Statistics. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/livebirths\/bulletins\/birthcharacteristicsinenglandandwales\/2019."},{"issue":"205","key":"2722_CR3","first-page":"51.e1","volume":"1976-2008","author":"AA Mitchell","year":"2011","unstructured":"Mitchell AA, et al. Medication use during pregnancy, with particular focus on prescription drugs. 2011;1976-2008(205):51.e1\u20138.","journal-title":"Medication use during pregnancy, with particular focus on prescription drugs"},{"key":"2722_CR4","doi-asserted-by":"publisher","first-page":"128312","DOI":"10.1371\/journal.pone.0128312","volume":"10","author":"K Smolina","year":"2015","unstructured":"Smolina K, Hanley GE, Mintzes B, Oberlander TF, Morgan S. Trends and determinants of prescription drug use during pregnancy and postpartum in British Columbia, 2002\u20132011: a population-based cohort study. PLoS One. 2015;10:128312.","journal-title":"PLoS One"},{"key":"2722_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00228-004-0775-7","volume":"60","author":"J Headley","year":"2004","unstructured":"Headley J, Northstone K, Simmons H, Golding J. Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children. Eur. J. Clin. Pharmacol. 2004;60:355\u201361.","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2722_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/AOG.0000000000002579","volume":"131","author":"D.M., H.","year":"2018","unstructured":"D.M., H., et al. Prescription and other medication use in pregnancy. Obstet. Gynecol. 2018;131:789\u201398.","journal-title":"Obstet. Gynecol."},{"key":"2722_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/pds.1269","volume":"15","author":"JR Hardy","year":"2006","unstructured":"Hardy JR, Leaderer BP, Holford TR, Hall GC, Bracken MB. Safety of medications prescribed before and during early pregnancy in a cohort of 81 975 mothers from the UK General Practice Research Database. Pharmacoepidemiol. Drug Saf. 2006;15:555\u201364.","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"2722_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:1\u201310.","journal-title":"BMC Geriatr."},{"key":"2722_CR9","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2147\/CLEP.S230589","volume":"11","author":"J Zhang","year":"2019","unstructured":"Zhang J, Ung COL, Wagner AK, Guan X, Shi L. Medication use during pregnancy in mainland China: a cross-sectional analysis of a national health insurance database. Clin. Epidemiol. 2019;11:1057\u201365.","journal-title":"Clin. Epidemiol."},{"key":"2722_CR10","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.4314\/ahs.v20i3.24","volume":"20","author":"ST Obadeji","year":"2020","unstructured":"Obadeji ST, Obadeji A, Bamidele JO, Ajayi FT. Medication use among pregnant women at a secondary health institution: utilisation patterns and predictors of quantity. Afr. Health Sci. 2020;20:1206.","journal-title":"Afr. Health Sci."},{"issue":"55","key":"2722_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s002280050608","volume":"552","author":"C Olesen","year":"1999","unstructured":"Olesen C, et al. Drug use in first pregnancy and lactation: a population-based survey among Danish women. Eur. J. Clin. Pharmacol. 1999;552(55):139\u201344.","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2722_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/pds.1906","volume":"19","author":"BJ Cleary","year":"2010","unstructured":"Cleary BJ, et al. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women. Pharmacoepidemiol. Drug Saf. 2010;19:408\u201317.","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"2722_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2125.2008.03102.x","volume":"65","author":"A Engeland","year":"2008","unstructured":"Engeland A, et al. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004-2006. Br. J. Clin. Pharmacol. 2008;65:653\u201360.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2722_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00228-003-0584-4","volume":"59","author":"H Malm","year":"2003","unstructured":"Malm H, Martikainen J, Klaukka T, Neuvonen PJ. Prescription drugs during pregnancy and lactation--a Finnish register-based study. Eur. J. Clin. Pharmacol. 2003;59:127\u201333.","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2722_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/CLEP.S16305","volume":"3","author":"O Stephansson","year":"2011","unstructured":"Stephansson O, et al. Drug use during pregnancy in Sweden \u2013 assessed by the Prescribed Drug Register and the Medical Birth Register. Clin. Epidemiol. 2011;3:43.","journal-title":"Clin. Epidemiol."},{"key":"2722_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.clinthera.2011.11.025","volume":"34","author":"JR Daw","year":"2012","unstructured":"Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001\u20132006). Clin. Ther. 2012;34:239\u2013249.e2.","journal-title":"Clin. Ther."},{"key":"2722_CR17","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ajog.2004.04.025","volume":"191","author":"SE Andrade","year":"2004","unstructured":"Andrade SE, et al. Prescription drug use in pregnancy. Am. J. Obstet. Gynecol. 2004;191:398\u2013407.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2722_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/pharmacy5020021","volume":"5","author":"H Nishigori","year":"2017","unstructured":"Nishigori H, et al. Drug use before and during pregnancy in Japan: the Japan Environment and Children\u2019s Study. Pharmacy (Basel). 2017;5:21.","journal-title":"Pharmacy (Basel)"},{"key":"2722_CR19","doi-asserted-by":"publisher","unstructured":"Guthrie B, Mccowan C, Davey P, Simpson CR, Dreischulte T, Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ. 2011;342:d3514\u2013d3514. https:\/\/doi.org\/10.1136\/bmj.d3514.","DOI":"10.1136\/bmj.d3514"},{"key":"2722_CR20","first-page":"901","volume":"19","author":"FT Bourgeois","year":"2010","unstructured":"Bourgeois FT, Shannon MW, Valim C, Mandl KD. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacofile\/\/\/Users\/astha\/Downloads\/adverse event bourgeous.pdfepidemiology. Drug Saf. 2010;19:901\u201310.","journal-title":"Drug Saf."},{"key":"2722_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12916-015-0322-7","volume":"13","author":"B Guthrie","year":"2015","unstructured":"Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med. 2015;13:74.","journal-title":"BMC Med."},{"key":"2722_CR22","doi-asserted-by":"publisher","unstructured":"Stirland LE, Gonz\u00e1lez-Saavedra L, Mullin DS, Ritchie CW, Muniz-Terrera G, Russ TC. Measuring multimorbidity beyond counting diseases: systematic review of community and population studies and guide to index choice. BMJ. 2020;m160. https:\/\/doi.org\/10.1136\/bmj.m160.","DOI":"10.1136\/bmj.m160"},{"key":"2722_CR23","unstructured":"M Whitty, C. J. et al. Rising to the challenge of multimorbidity. doi.org\/10.1136\/bmj.l6964."},{"key":"2722_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37\u201343.","journal-title":"Lancet"},{"key":"2722_CR25","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int. J. Epidemiol. 2015;44:827\u201336.","journal-title":"Int. J. Epidemiol."},{"key":"2722_CR26","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/pds.4811","volume":"28","author":"C Minassian","year":"2019","unstructured":"Minassian C, et al. Methods to generate and validate a pregnancy register in the UK Clinical Practice Research Datalink primary care database. Pharmacoepidemiol. Drug Saf. 2019;28:923\u201333.","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"2722_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.1365-2532.1994.1130177.x","volume":"11","author":"N Booth","year":"1994","unstructured":"Booth N. What are the Read Codes? Health Libr. Rev. 1994;11:177\u201382.","journal-title":"Health Libr. Rev."},{"key":"2722_CR28","unstructured":"CPRD. Release notes: CPRD GOLD May 2022. 2022. Available from: https:\/\/cprd.com\/sites\/default\/files\/2022-05\/2022-05%20CPRD%20GOLD%20Release%20Notes.pdf. Accessed Dec 2022."},{"key":"2722_CR29","unstructured":"79 health conditions: defining 2 or more long-term health conditions in pregnancy \u2013 MuM-PreDiCT. https:\/\/mumpredict.org\/79-health-conditions-defining-2-or-more-long-term-health-conditions-in-pregnancy\/."},{"key":"2722_CR30","unstructured":"All BNF sections | OpenPrescribing. https:\/\/openprescribing.net\/bnf\/."},{"key":"2722_CR31","unstructured":"Preface | About | BNF content published by NICE. https:\/\/bnf.nice.org.uk\/about\/preface.html."},{"key":"2722_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejogrb.2003.10.024","volume":"114","author":"E Schirm","year":"2004","unstructured":"Schirm E, Meijer WM, Tobi H, Den Berg DJ-V, L. T. W. Drug use by pregnant women and comparable non-pregnant women in the Netherlands with reference to the Australian classification system. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004;114:182\u20138.","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"2722_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/pds.4355","volume":"27","author":"KG Ingstrup","year":"2018","unstructured":"Ingstrup KG, Liu X, Gasse C, Debost JCP, Munk-Olsen T. Prescription drug use in pregnancy and variations according to prior psychiatric history. Pharmacoepidemiol. Drug Saf. 2018;27:105\u201313.","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"2722_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/humrep\/det369","volume":"29","author":"MMHJ Van Gelder","year":"2014","unstructured":"Van Gelder MMHJ, Bos JHJ, Roeleveld N, Den Berg DJ-V, L. T. W. Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998\u20132009. Hum. Reprod. 2014;29:161\u20137.","journal-title":"Hum. Reprod."},{"key":"2722_CR35","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s10995-014-1611-z","volume":"19","author":"SC Tinker","year":"2015","unstructured":"Tinker SC, Broussard CS, Frey MT, Gilboa SM. Prevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United HHS Public Access. Matern Child Heal. J. 2015;19:1097\u2013106.","journal-title":"Matern Child Heal. J"},{"key":"2722_CR36","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/S0140-6736(00)03209-8","volume":"356","author":"I Lacroix","year":"2000","unstructured":"Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL. Prescription of drugs during pregnancy in France. Lancet. 2000;356:1735\u20136.","journal-title":"Lancet"},{"key":"2722_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1055\/s-2005-873235","volume":"22","author":"JS Refuerzo","year":"2005","unstructured":"Refuerzo JS, et al. Use of over-the-counter medications and herbal remedies in pregnancy. Am. J. Perinatol. 2005;22:321\u20134.","journal-title":"Am. J. Perinatol."},{"key":"2722_CR38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00228-006-0119-x","volume":"62","author":"C Olesen","year":"2006","unstructured":"Olesen C, Thrane N, Henriksen TB, Ehrenstein V, Olsen J. Associations between socio-economic factors and the use of prescription medication during pregnancy: a population-based study among 19,874 Danish women. Eur. J. Clin. Pharmacol. 2006;62:547\u201353.","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2722_CR39","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s40264-015-0302-z","volume":"38","author":"L de Jonge","year":"2015","unstructured":"de Jonge L, de Walle HEK, de Jong-van den Berg, L. T. W., van Langen, I. M. & Bakker, M. K. Actual use of medications prescribed during pregnancy: a cross-sectional study using data from a population-based congenital anomaly registry. Drug Saf. 2015;38:737\u201347.","journal-title":"Drug Saf."},{"key":"2722_CR40","doi-asserted-by":"publisher","first-page":"e821","DOI":"10.3399\/bjgp12X659295","volume":"62","author":"A Calder\u00f3n-Larra\u00f1aga","year":"2012","unstructured":"Calder\u00f3n-Larra\u00f1aga A, et al. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br. J. Gen. Pract. 2012;62:e821\u20136.","journal-title":"Br. J. Gen. Pract."},{"key":"2722_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.15256\/joc.2015.5.51","volume":"5","author":"C Sinnott","year":"2015","unstructured":"Sinnott C, Bradley CP. Multimorbidity or polypharmacy: two sides of the same coin? J. Comorbidity. 2015;5:29.","journal-title":"J. Comorbidity"},{"key":"2722_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-020-01580-1","volume":"20","author":"N Vill\u00e9n","year":"2020","unstructured":"Vill\u00e9n N, et al. Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study. BMC Geriatr. 2020;20:1\u201313.","journal-title":"BMC Geriatr."},{"key":"2722_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/fampra\/cmz023","volume":"36","author":"TN Nguyen","year":"2019","unstructured":"Nguyen TN, Ngangue P, Haggerty J, Bouhali T, Fortin M. Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study. Fam. Pract. 2019;36:706\u201312.","journal-title":"Fam. Pract."},{"key":"2722_CR44","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamapsychiatry.2020.2453","volume":"77","author":"KN Anderson","year":"2020","unstructured":"Anderson KN, et al. Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects. JAMA Psychiatry. 2020;77:1246\u201355.","journal-title":"JAMA Psychiatry"},{"key":"2722_CR45","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/S0049-3848(15)50446-5","volume":"135","author":"S Hoirisch-Clapauch","year":"2015","unstructured":"Hoirisch-Clapauch S, Brenner B, Nardi AE. Adverse obstetric and neonatal outcomes in women with mental disorders. Thromb. Res. 2015;135:S60\u20133.","journal-title":"Thromb. Res."},{"key":"2722_CR46","unstructured":"Who can get free prescriptions - NHS. https:\/\/www.nhs.uk\/nhs-services\/prescriptions-and-pharmacies\/who-can-get-free-prescriptions\/."},{"key":"2722_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1576\/toag.9.3.153.27334","volume":"9","author":"RP Horgan","year":"2007","unstructured":"Horgan RP, Kenny LC, Horgan R, Mrcpi M, Kenny LC. Management of teenage pregnancy. Obstet. Gynaecol. 2007;9:153\u20138.","journal-title":"Obstet. Gynaecol."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02722-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02722-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02722-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T13:07:35Z","timestamp":1673874455000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02722-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2722"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02722-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"6 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Observational research using CPRD data was approved by National Research Ethics Service Committee. This study has been approved by the Independent Scientific Advisory Committee (Reference: 20_181R). As CPRD data are anonymized, individual patients are not required to give consent for the use of their data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}